Sangamo Therapeutics
SGMO
#8888
Rank
NZ$0.24 B
Marketcap
NZ$0.74
Share price
-6.56%
Change (1 day)
-82.62%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2025 (TTM): NZ-$0.76

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.75. In 2024 the company made an earnings per share (EPS) of NZ-$0.87.

EPS history for Sangamo Therapeutics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.76-12.52%
2024NZ-$0.87
2022NZ-$2.140.81%
2021NZ-$2.1233.33%
2020NZ-$1.596.9%
2019NZ-$1.4922.54%
2018NZ-$1.211.43%
2017NZ-$1.20-31.37%
2016NZ-$1.7475.86%
2015NZ-$0.9948.72%
2014NZ-$0.67-17.02%
2013NZ-$0.809.3%
2012NZ-$0.74-39.44%
2011NZ-$1.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
NZ$11.15-1,581.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.15-120.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$22.29-3,061.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.80-2,597.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ-$2.77 268.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.85-2,472.59%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$4.65-718.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.99-1,825.86%๐Ÿ‡บ๐Ÿ‡ธ USA